Careers  |  Sign In  |  Register  |   Twitter

Latest in Cardiology

Farouk Parker, MD, Chief Medical Officer, CUNARD, Queen Mary 2, discusses the Emergency Response System aboard the Queen Mary 2.
The FDA cleared for marketing the first replacement heart valve from donated human tissue in which the cells have been removed. References and Resources FDA Clears for Market First Decellularized Heart Valve Sponsored by The Doctor’s...

No significant difference in primary endpoint

ENHANCE: Ezetimibe Plus Simvastatin versus Simvastatin Alone

ENHANCE was a surrogate endpoint trial conducted in 720 patients with Heterozygous Familial Hypercholesterolemia. This study showed no significant difference in the primary endpoint between patients treated with ezetimibe plus simvastatin versus patients treated with simvastatin alone over a two-year period....